Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...

Despite the continued success of GLP-1 drugs Ozempic and Wegovy, Novo Nordisk CEO Lars Fruergaard Jørgensen took a slight pay cut in 2024. He received 57.1 million Danish kroner (DKK) — $8 million — ...

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

Vasant Narasimhan took over as CEO of Novartis, one of the world’s largest pharmaceutical companies, in 2018. Originally from Pittsburgh, Narasimhan attended the University of Chicago and ...

At Novartis, CEO Vas Narasimhan’s overall 2024 pay increased by 6.9% at grant value, reaching 14.2 million Swiss francs ($15.7 million), according to the company’s annual report (PDF).

CEO Vas Narasimhan pointed out during the Q4 2024 Earnings Call that if these yield positive results, Cosentyx would have further growth engines for the rest of this decade. Additionally ...

In response, Novartis CEO Vas Narasimhan, M.D., said, “We’ve had to give the appropriate level of adjustments on our rebates, but we've maintained [a] very good formulary position,” adding ...

CEO Vas Narasimhan said after its earnings call last week that the drugmaker had done 30 such deals in the past year. The Trump administration’s sudden freeze on funds to USAID has caused ...